10160- COT-18 DIFFERENCES IN 5-ALA FINDINGS AND BRIGHTNESS ON SECOND SURGERY
Takashi Kon, Yusuke Kobayashi, Yosuke Sato, Katsuyoshi Shimizu, Tohru Mizutani · 2024
Read 10160- COT-18 DIFFERENCES IN 5-ALA FINDINGS AND BRIGHTNESS ON SECOND SURGERY by Takashi Kon, Yusuke Kobayashi, Yosuke Sato, Katsuyoshi Shimizu, Tohru Mizutani (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605579.txt.
Description
Takashi Kon and co-authors report in a 2024 conference study four brain tumor cases where a glow test changed its mind between first and second surgery. Patients take a drug, 5-ALA, that makes tumor tissue glow under the knife, guiding removal. All four had radiation and drug therapy between operations.
In two cases the glow flipped from absent to strong at the second surgery; in two it stayed strong. One flipped case proved to be radiation damage, not tumor, and the others kept their first diagnosis. Tumor change alone does not explain the flips, the team notes; prior treatment may alter the glow.
Catalog record
| CREATOR | Takashi Kon, Yusuke Kobayashi, Yosuke Sato, Katsuyoshi Shimizu, Tohru Mizutani |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |